COMMUNIQUÉS West-GlobeNewswire

La FDA confirme la date-cible pour une décision sur la nouvelle formulation en fiole unique d’EGRIFTA(MD) (tésamoréline pour injection)
05/09/2018
MONTRÉAL, 05 sept. 2018 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies ») (TSX: TH) a annoncé aujourd’hui que la Food and Drug Administration (« FDA ») a établi au 3 novembre 2018 la date-cible pour une [...]
KemPharm to Present at Two Healthcare Investor Conferences During September 2018
05/09/2018
CORALVILLE, Iowa, Sept. 05, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced today that its President [...]
Dermira Provides Launch Readiness Update for QBREXZA™ (glycopyrronium) Cloth for Primary Axillary Hyperhidrosis
05/09/2018
Early commercial payer coverage for the therapy includes Express Scripts, Inc. and OptumRx Company announces DermiraConnect, a new patient access program that will provide patients broad access to QBREXZA Therapy is [...]
Opthea Receives Positive Interim Review from Independent Safety Committee in Phase 2b Wet AMD Clinical Trial
05/09/2018
MELBOURNE, Australia, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing novel biologic therapies to treat back-of-the eye diseases, today announced that the [...]
Histogenics Announces Top-Line Results From Phase 3 Clinical Trial of NeoCart® in Patients With Knee Cartilage Damage
05/09/2018
‒ Phase 3 Clinical Trial of NeoCart Did Not Meet Primary Endpoint of a Statistically Significant Improvement in Pain and Function in a Dual Threshold Responder Analysis One Year After Treatment as Compared to [...]
electroCore to Present Additional Research for Non-invasive Vagus Nerve Stimulation in Headache Disorders at the 17th Biennial Migraine Trust International Symposium
05/09/2018
BASKING RIDGE, N.J., Sept. 05, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that seven abstracts and an oral presentation featuring non- [...]
ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial
05/09/2018
QR-110 demonstrated rapid and sustained improvement in vision in the majority of subjects, as measured by visual acuity and mobility course QR-110 was well-tolerated with no serious adverse events A Phase 2/3 pivotal [...]
Biohit GastroPanel® accurately predicted the progression of atrophic gastritis and its transition to gastric cancer in a European multicenter trial
05/09/2018
Biohit Oyj press release 05.09.2018 klo 10.10 local time (EEST) A Dutch research group working at Erasmus University (Rotterdam), headed by internationally recognized professor Kuipers, together with Norwegian [...]
Active Biotech regains global rights to development and commercialization of laquinimod
05/09/2018
PRESS RELEASE Lund Sweden, September 5, 2018 - Active Biotech (NASDAQ OMX NORDIC: ACTI) announced today that it regains the global development and commercialization rights to laquinimod from Teva Pharmaceutical [...]
Chi-Med Announces the Approval of Fruquintinib Capsules for Previously Treated Colorectal Cancer in China
05/09/2018
– Fruquintinib capsules provide a new oral treatment option for patients with metastatic colorectal cancer and will be marketed as Elunate ® – – Elunate ® data published in JAMA demonstrated increased overall survival [...]
Motif Bio Presents Iclaprim Data at ESCMID/ASM Conference
05/09/2018
Iclaprim overview presented in State of the Art Lecture Safety analysis of diabetic patients in REVIVE ABSSSI trials shows fewer adverse events versus vancomycin Surveillance data confirm in vitro activity of iclaprim [...]
Immunocore strengthens IP position in the field of TCR-based therapeutics
05/09/2018
PRESS RELEASE Immunocore strengthens IP position in the field of TCR-based therapeutics Notice of Allowance received from US patent and trademark office relating to ImmTAC® platform (Oxford, UK and Conshohocken, US, 5 [...]
DBV Technologies, Geneva University Hospitals and BioNet-Asia Presented Additional Phase I Data on the Use of an Investigational Epicutaneous Patch in Boosting Pertussis Vaccination at the ECI
05/09/2018
DBV Technologies, Geneva University Hospitals and BioNet-Asia Presented Additional Phase I Data on the Use of an Investigational Epicutaneous Patch in Boosting Pertussis Vaccination at the European Congress of [...]
DBV, les HUG et BioNet ont présenté les données additionnelles d'une étude de phase I sur l'utilisation d'un patch épicutané expérimental en vaccination de rappel contre la coqueluche lors de l'ECI
05/09/2018
DBV Technologies, les Hôpitaux Universitaires de Genève et BioNet-Asia ont présenté les données additionnelles d'une étude de phase I sur l'utilisation d'un patch épicutané expérimental en vaccination de rappel contre [...]
MediciNova to Attend the Morgan Stanley Global Healthcare Conference in New York
05/09/2018
LA JOLLA, Calif., Sept. 04, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), [...]
Veritas Appoints Lorne Mark Roseborough CEO of SunVault Energy to the Board of Directors
05/09/2018
VANCOUVER, British Columbia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) ( “ Veritas ” or the “Company”) is pleased to announce the appointment of Lorne Mark [...]
CO2 GRO Inc. Engages a Senior Scientist in a Shares for Service Agreement
05/09/2018
TORONTO, Sept. 04, 2018 (GLOBE NEWSWIRE) -- CO2 GRO Inc. (“ CO2GRO ” or “ GROW ”) (TSX-V:GROW) announces that it has entered into an agreement with Dr. Luc Duchesne (“ Duchesne ”). Dr. Duchesne, PhD., Plant Biochemistry [...]
Agios Announces Chief Executive Officer Succession Plan
04/09/2018
- David Schenkein, M.D., Agios Long-Time Chief Executive Officer, to Become Executive Chairman, Effective February 1, 2019 - - Jacqualyn Fouse, Ph.D., to Succeed Dr. Schenkein as Chief Executive Officer - CAMBRIDGE, [...]
IMV Inc. Celebrates Grand Opening of New Facility in Dartmouth, Nova Scotia
04/09/2018
DARTMOUTH, Nova Scotia, Sept. 04, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, celebrated its grand opening today of its new facilities in Dartmouth, Nova [...]

Pages